LensAR
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 30.5m | 26.4m | 34.5m | 35.4m | 42.2m | 50.8m | 61.7m |
% growth | - | (14 %) | 31 % | 3 % | 19 % | 20 % | 21 % |
EBITDA | (8.8m) | (17.2m) | (18.4m) | (19.0m) | (5.9m) | - | - |
% EBITDA margin | (29 %) | (65 %) | (53 %) | (54 %) | (14 %) | - | - |
Profit | (14.7m) | (19.8m) | (19.6m) | (19.9m) | (14.4m) | - | - |
% profit margin | (48 %) | (75 %) | (57 %) | (56 %) | (34 %) | - | - |
R&D budget | 7.6m | 7.6m | 12.4m | 11.8m | 6.1m | - | - |
R&D % of revenue | 25 % | 29 % | 36 % | 33 % | 15 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $7.1m | Early VC | |
N/A | $7.0m | Early VC | |
N/A | $2.0m | Debt | |
N/A | $1.4m | Debt | |
$24.0m | Debt | ||
$10.0m | Debt | ||
N/A | N/A | Series A | |
$27.0m | - | ||
N/A | $10.0m | Growth Equity VC | |
N/A | $16.0m | Growth Equity VC | |
Total Funding | €61.0m |
Recent News about LensAR
EditLENSAR, Inc. is a pioneering company in the field of refractive cataract surgery, specializing in next-generation femtosecond laser technology. The company focuses on providing advanced laser systems that enable surgeons to perform personalized and precise cataract procedures. LENSAR serves ophthalmologists and their patients, primarily targeting the healthcare and medical device markets. The business model revolves around the sale of its laser systems and related services, generating revenue through direct sales and ongoing service agreements. By understanding the dynamic needs of surgeons and patients, LENSAR continuously innovates its technology to ensure optimal outcomes. The company operates in a highly specialized niche, offering unique solutions that enhance surgical precision and patient outcomes.
Keywords: femtosecond laser, cataract surgery, ophthalmology, medical devices, refractive surgery, precision, innovation, healthcare, personalized treatment, surgical technology.